Arcutis Biotherapeutics Insider Sold Shares Worth $1,411,513, According to a Recent SEC Filing

04:12 AM EST, 11/05/2026 (MT Newswires) -- Masaru Matsuda, Executive Vice President, Chief Legal Officer, on November 02, 2026, sold 41,219 shares in Arcutis Biotherapeutics (ARQT) for $1,411,513. Following the Form 4 filing with the SEC, Matsuda has control over a total of 111,289 common shares of the company, with 111,289 shares held directly. The transaction was effected pursuant to a 10b5-1 trading plan adopted on June 5 by the reporting person. SEC Filing: https://www.sec.gov/Archives/edgar/data/1787306/000162828026070385/xslF345X05/wk-form4_1793835532.xml